JP Stock MarketDetailed Quotes

4151 Kyowa Kirin

Watchlist
  • 2159.0
  • -18.5-0.85%
20min DelayTrading Mar 21 09:49 JST
1.13TMarket Cap19.10P/E (Static)

About Kyowa Kirin Company

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Company Profile

Symbol4151
Company NameKyowa Kirin
Founded1949-07-01
MarketTSE Prime
Employees5669
Fiscal Year Ends12-31
Address1-9-2,Otemachi, Chiyoda-ku Otemachi Financial City Grand Cube
Zip Code100-0004
Phone03-5205-7200

Company Executives

  • Name
  • Position
  • Salary
  • Masashi Miyamoto
  • Director, President and Chief Executive Officer
  • --
  • Yutaka Osawa
  • Director and Chief Compliance Officer
  • --
  • Takeyoshi Yamashita
  • Director, Chief Medical Officer and Senior Managing Executive Officer
  • --
  • Shinjiro Akieda
  • Director
  • --
  • Yoshihisa Suzuki
  • Independent Director
  • --
  • Takashi Oyamada
  • Independent Director
  • --
  • Akira Morita
  • Independent Director
  • --
  • Yuko Haga
  • Independent Director
  • --
  • Rumiko Nakata
  • Independent Director
  • --

Market Insights

Discussing
地產板塊回暖!中國資產能否延續漲勢?
3月17日早盤,地產代理、物業服務及管理等板塊漲幅明顯,貝殼-W早盤漲逾4%,碧桂園服務漲逾9%。政策消息面上,兩部門發文落實專項債支持收地,中房協組織民營房企座談會。中國資產本輪火爆行情還能持續多久?你會如何投資? Show More